FDA
-
-
-
-
-
-
-
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 24, 2022
-
-
-
-
-
-
-
ERYTECH (ERYP) Reports Publication of Positive Results from Eryaspase Phase 2 Trial in Hypersensitive ALL in the British Journal of Haematology
-
-
-
-
-
-
-
ERYTECH to Participate in the Upcoming January Virtual Investor Conferences
-
-
-
-
-
-
-
ERYTECH Secures US Patent Directed to Sequential Use of Methioninase & Asparaginase against Solid Tumors
-
-
-
-
-
-
-
ERYTECH Announces Maximum Tolerated Dose Declared in a Phase 1 Investigator Sponsored Trial of Eryaspase in First-Line Pancreatic Cancer
-
-
-
-
-
-
-
Pre-Open Movers 07/30: (ERYP) (TEAM) (MSON) Higher; (PINS) (ZYXI) (AMZN) Lower (more...)
-
-
-
-
-
-
-
ERYTECH to Participate in Upcoming Virtual Investor Conferences in June
-
251,413 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All